For instance, it has been documented that plasma concentrations of some substrates of CYP3A enzymes (lopinavir, darunavir, and direct oral anticoagulants) are significantly higher in patients with COVID-19 [405,406,407,408]. Here, CYP3A4 is linked to COVID-19.